TABLE 2.

Main characteristics of the included studies¹

			Mean age		Participants, n		LE administration
Reference	Location	Intervention2	Treatment	Control	Enrolled	Completed	Reasons	Days
Antébi et al. (17)	France	SMOF LE	70 y	51 y	20	20	Major surgery	5
Cano et al. (27)	France	Olive oil LE	73.2 y	66.5 y	41	35	Malnourished hemodialysis	35
Deshpande et al. (12)	Australia	Olive oil LE	26.14 wk	25.92 wk	50	45	Premature birth	5
Gawecka et al. (26)	Poland	Olive oil LE	27 wk	27 wk	44	38	Premature birth	14
Gobel et al. (29)	Germany	Olive oil LE	220 d	224 d	42	33	Premature birth	7
Goulet et al. (28)	France	Olive oil LE	4 y	3 y	18	18	Short-bowel syndrome, intractable diarrhea, CIP	60
Goulet et al. (31)	Germany	SMOF LE	30.3 mo	38.8 mo	28	28	Short-bowel syndrome, CIP	28
Grimm et al. (33)	Germany	SMOF LE	63.1 y	61.1 y	33	33	Major abdominal surgery	5
Klek et al. (32)	Poland	SMOF LE	53.2 y	45.2 y	75	62	Short bowel syndrome, Crohn disease, malabsorption	28
Koksal et al. (24)	India	Olive oil LE	30.2 wk	30.4 wk	64	64	Premature birth	7
Mertes et al. (14)	Germany	SMOF LE	60.5 y	60.2 y	249	199	Elective abdominal or thoracic surgery	5
Rayyan et al. (34)	Germany	SMOF LE	29.9 wk	30.4 wk	53	46	Premature birth	14
Tomsits et al. (16)	Hungary	SMOF LE	31.7 wk	31.9 wk	60	51	Premature birth	14
Vahedi et al. (25)	France	Olive oil LE	48 y	53 y	13	13	Short-bowel syndrome, CIP	90
Webb et al. (30)	Australia	Olive oil LE	37.0 wk	36.7 wk	80	78	Critically ill	5

¹CIP, chronic intestinal pseudo-obstruction; LE, lipid emulsion; SMOF, soybean oil, medium-chain TGs, olive oil, and fish oil.

²Relative to soybean oil LE (control).